About this time each year I blog about how much I hate cancer. This year, it’s a bit tougher as my father was diagnosed with advanced head and neck cancer in June. Once again I am reminded about the difference it makes to be knowledgeable about clinical trials when making treatment decisions. We ask more questions. We explore more options. We filter what we hear through experience. And, we know when the informed consent process isn’t being done well – or even in compliance with regulations.
If you follow Humans of New York (HONY) on Facebook – and with more than 17 million followers, I expect you do – then you’ve been inspired by and often heartsick over this week’s stories told from the Pediatrics Department of Memorial Sloan Kettering Cancer Center.
It feels like we’re always on our mobile devices. But what exactly are we doing when we’re on them? Sure, we make phone calls, check email, and browse the web. But in terms of average mobile usage, we spend nearly 80 percent of our time in apps. With many of those apps being supported through paid advertisements, in-app advertising is creating exciting new opportunities for clinical trial marketers to identify, segment, and target potential participants inside the mobile universe.